RSKD (RSKD) Form 144 shows 105,587-share planned NYSE sale

Rhea-AI Filing Summary

RSKD received a Form 144 notice indicating a planned sale of restricted common stock by a shareholder. The notice covers up to 105,587 common shares, with an aggregate market value of $525,823.26, to be sold through Morgan Stanley Smith Barney LLC on the NYSE around December 9, 2025. The shares relate to founder shares acquired on November 26, 2012 and restricted stock units acquired on January 1, 2025. Over the prior three months, a Rule 10b5-1 trading plan for Assaf Feldman sold 3,487 shares for gross proceeds of $17,016.56. The issuer had 112,306,279 shares outstanding at the time stated.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	105587	525823.26	112306279	12/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/26/2012	Founders Shares	ISSUER			75000	11/26/2012	N/A
Common	01/01/2025	Restricted Stock Units	Issuer			30587	01/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ASSAF FELDMAN 220 5th Avenue, 2nd Floor New York NY 10001	Common	11/28/2025	3487	17016.56

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for RSKD disclose?

The Form 144 notice discloses a planned sale of up to 105,587 shares of common stock of RSKD, with an aggregate market value of $525,823.26, to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

Who is selling RSKD shares and how were they acquired?

The filing relates to sales for Assaf Feldman. The shares to be sold come from founder shares acquired on November 26, 2012 and restricted stock units acquired on January 1, 2025.

How many RSKD shares are outstanding in this Form 144 notice?

The notice states that the issuer had 112,306,279 shares of common stock outstanding as of the time referenced in the filing.

What recent RSKD share sales are reported for the past three months?

The document reports that a Rule 10b5-1 trading plan for Assaf Feldman sold 3,487 common shares on November 28, 2025, generating $17,016.56 in gross proceeds.

When are the RSKD shares in this Form 144 expected to be sold?

The notice lists an approximate date of sale of December 9, 2025 for the planned sale of the 105,587 common shares on the NYSE.

What trading plan or certification is referenced in the RSKD Form 144?

The filing references Rule 10b5-1 sales for Assaf Feldman and includes a representation that the person selling does not know of any undisclosed material adverse information about the issuer.